Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
RDA Recommended Dietary AllowancesCorrelations of DTAC with nutrient intakes and food groupsVariableCases (n = 34)r/pControls (n = 34)r/pMacronutrients and Micronutrients Energy (kcal/day)0.331/0.028−0.123/0.240 Carbohydrate (g/day)0.241/0.0850.034/0.424 Carbohydrate (% energy)−0.183/0.150−0.018/0.460 Protein (g/day)0.464/0.003**0.111/0.263 Protein (% energy)0.296/0.044*0.150/0.195 Fat (% energy)0.134/0.225−0.016/0.463 Saturated fatty acids (%)−0.146/0.2050.156/0.186 Linoleic acid (% energy)−0.138/0.2190.033/0.425 Alpha-linolenic acid (% energy)−0.075/0.3370.036/0.419 Fiber (g/day)0.134/0.2240.160/0.180 Calcium (mg/day)−0.402/0.009**−0.155/0.187 Iron (mg/day)0.146/0.204−0.120/0.249 Magnesium (mg/day)0.026/0.4420.026/0.441 Phosphorus (mg/day)0.103/0.2820.132/0.225 Potassium (mg/day)0.159/0.184−0.159/0.181 Sodium (mg/day)0.021/0.453−0.055/0.378 Zinc (mg/day)−0.051/0.3870.017/0.462 Copper (mg/day)0.162/0.180−0.314/0.033* Vitamin A (µg RE/day)0.162/0.1800.068/0.350 Vitamin D (µg/day)−0.052/0.3840.120/0.246 Vitamin E (mg/day)0.414/0.007**−0.070/0.344 Vitamin K (µg/day)0.087/0.3120.151/0.193 Vitamin C (mg/day)0.242/0.0840.123/0.241 Thiamin (mg/day)0.200/0.129−0.043/0.402 Riboflavin (mg/day)−0.001/0.497−0.150/0.194 Vitamin B6 (mg/day)−0.168/0.1720.006/0.486 Vitamin B12 (µg/day)−0.129/0.2330.058/0.370 Folate (µg/day)−0.001/0.498−0.088/0.308 Niacin (mg NE/day)0.125/0.2410.214/0.108Food Groups Milk (g/day)0.013/0.471−0.145/0.203 Yogurt (g/day)0.131/0.2310.076/0.333 Cheese (g/day)0.187/0.1440.315/0.033 Red meat (g/day)−0.142/0.212−0.152/0.192 Poultry (g/day)0.100/0.287−0.041/0.408 Fish and seafood (g/day)−0.012/0.4740.174/0.159 Organ meats (g/day)0.239/0.086−0.093/0.298 Processed meat (g/day)0.182/0.1520.104/0.276 Eggs (g/day)0.279/0.0550.373/0.014* Legumes (g/day)0.288/0.049*0.074/0.337 Green vegetables (g/day)0.458/0.003**0.571/≤ 0.001** Vegetables (g/day)0.520/0.001**0.632/≤ 0.001** Citrus fruits (g/day)0.432/0.005*0.206/0.118 Fresh fruits (g/day)0.347/0.0220.535/≤ 0.001** Fruit juice (ml/day)0.331/0.0280.210/0.113 White bread (g/day)−0.165/0.176−0.132/0.225 Whole grain bread (g/day)0.580/≤ 0.001**0.391/0.010* Rice, bulgur, pasta (g/day)0.197/0.131−0.018/0.458 Cakes, pastries, biscuits (g/day)−0.246/0.0800.081/0.323 Olive oil (g/day)0.296/0.045*0.196/0.129 Sunflower oil (g/day)0.069/0.349−0.217/0.105 Margarine (g/day)0.193/0.137−0.135/0.219 Olives (g/day)0.253/0.0750.247/0.076 Butter (g/day)0.088/0.3100.311/0.035* Packaged fruit juice (g/day)−0.081/0.325−0.273/0.056 Nuts (g/day)0.292/0.047*0.408/0.007* Honey, jam, molasses (g/day)−0.236/0.089−0.062/0.362 Coffee (ml/day)0.719/≤ 0.0001**0.258/0.067 Black tea (ml/day)0.099/0.2890.472/0.002* Herbal tea (ml/day)0.360/0.018*0.135/0.220 Soft drinks (ml/day)0.183/0.150−0.170/0.165 Alcohol (ml/day)−0.008/0.482−0.039/0.412DTAC Dietary total antioxidant capacity, *Spearman correlation analysis. *p < 0.05, **p < 0.01
Source: Dietary total antioxidant capacity (DTAC) and dietary diversity. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Case-control study.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Nutritional status, dietary antioxidant capacity, and dietary diversity in patients with newly diagnosed hematological malignancies: a case: control study
Source: Article title.
Participants were eligible if they could undergo bioelectrical impedance analysis (BIA), were literate, and provided informed consent.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Nutritional status, dietary antioxidant capacity, and dietary diversity in patients with newly diagnosed hematological malignancies: a case-control study
Case-control study · Supportive Care in Cancer · 2026
Original publication title
Nutritional status, dietary antioxidant capacity, and dietary diversity in patients with newly diagnosed hematological malignancies: a case: control study
© The Author(s) 2026
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What objectives does the paper state?
Nutritional status and dietary antioxidant capacity are important determinants of clinical resilience in cancer; however, data in hematological malignancies remain limited. We aimed to compare nutritional status, dietary total antioxidant capacity (DTAC), and dietary diversity between patients with newly diagnosed hematological malignancies and healthy controls.
Source: PurposeAbstract: What methods does the paper describe?
This case: control study included 34 patients with newly diagnosed hematological malignancies (12 lymphoma, 11 leukaemia, 11 multiple myeloma) and 34 age: and sex-matched healthy controls aged 18 to 65 years. DTAC was estimated using the ferric reducing antioxidant power (FRAP) method based on a validated food frequency questionnaire. Nutrient intakes and the dietary diversity score (DDS) were derived from 3-day dietary records. Nutritional status was assessed using the Global Leadership Initiative on Malnutrition (GLIM) criteria, along with fat-free mass index (FFMI), and mid-upper arm circumference (MUAC).
Source: MethodsAbstract: Results
Patients had significantly lower DTAC levels than controls (3.85 ± 1.58 vs. 8.68 ± 3.21 mmol/day, p < 0.05). According to GLIM criteria, 35.3% of patients had moderate malnutrition and 26.5% had severe malnutrition, A declining trend in DTAC was observed with worsening malnutrition (p = 0.034), although this did not reach the significance threshold after multiplicity adjustment. Low muscle mass was more prevalent in patients as assessed by both FFMI and MUAC. Energy, protein, zinc, vitamin E, and folate intakes were significantly lower in patients (all p < 0.05), whereas DDS did not differ (p > 0.05).
DTAC was positively correlated with intakes of coffee, whole-grain bread, green vegetables, citrus fruits, and fresh fruit (p ≤ 0.05).
Source: ResultsAbstract: Conclusions
Significant differences in nutritional status and DTAC between patients and healthy individuals suggest that suboptimal dietary patterns may accompany hematological malignancies at diagnosis. These findings highlight the potential importance of adequate macro: and micronutrient intake; however, further prospective studies are needed to determine whether targeted nutritional interventions can improve clinical outcomes or contribute to long-term risk reduction.
Source: ConclusionsAuthors’ abstract
Purpose
Nutritional status and dietary antioxidant capacity are important determinants of clinical resilience in cancer; however, data in hematological malignancies remain limited. We aimed to compare nutritional status, dietary total antioxidant capacity (DTAC), and dietary diversity between patients with newly diagnosed hematological malignancies and healthy controls.
Methods
This case: control study included 34 patients with newly diagnosed hematological malignancies (12 lymphoma, 11 leukaemia, 11 multiple myeloma) and 34 age: and sex-matched healthy controls aged 18 to 65 years. DTAC was estimated using the ferric reducing antioxidant power (FRAP) method based on a validated food frequency questionnaire. Nutrient intakes and the dietary diversity score (DDS) were derived from 3-day dietary records. Nutritional status was assessed using the Global Leadership Initiative on Malnutrition (GLIM) criteria, along with fat-free mass index (FFMI), and mid-upper arm circumference (MUAC).
Results
Patients had significantly lower DTAC levels than controls (3.85 ± 1.58 vs. 8.68 ± 3.21 mmol/day, p < 0.05). According to GLIM criteria, 35.3% of patients had moderate malnutrition and 26.5% had severe malnutrition, A declining trend in DTAC was observed with worsening malnutrition (p = 0.034), although this did not reach the significance threshold after multiplicity adjustment. Low muscle mass was more prevalent in patients as assessed by both FFMI and MUAC. Energy, protein, zinc, vitamin E, and folate intakes were significantly lower in patients (all p < 0.05), whereas DDS did not differ (p > 0.05).
DTAC was positively correlated with intakes of coffee, whole-grain bread, green vegetables, citrus fruits, and fresh fruit (p ≤ 0.05).
Conclusions
Significant differences in nutritional status and DTAC between patients and healthy individuals suggest that suboptimal dietary patterns may accompany hematological malignancies at diagnosis. These findings highlight the potential importance of adequate macro: and micronutrient intake; however, further prospective studies are needed to determine whether targeted nutritional interventions can improve clinical outcomes or contribute to long-term risk reduction.
Publication and source details
Original title: Nutritional status, dietary antioxidant capacity, and dietary diversity in patients with newly diagnosed hematological malignancies: a case: control study
Busra Nur Koyuncu; Merve Yilmaz; Fatos Dilan Koseoglu
Supportive Care in Cancer · 2026
© The Author(s) 20262026https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.Izmir Tinaztepe UniversityOpen access funding provided by the Scientific and Technological Research Council of Türkiye (TÜBİTAK).
Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-10T22:22:38.897247+00:00
DOI: 10.1007/s00520-026-10817-5 · PMC13230294